Abbott Laboratories Stock: Abbott Shareholders Are Encouraged to Contact Kehoe Law Firm, P.C. to Discuss Potential Legal Claims

New York, New York--(Newsfile Corp. - September 13, 2022) - Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Abbott Laboratories ("Abbott") (NYSE: ABT) breached their fiduciary duties to Abbott and its shareholders.

The investigation concerns whether members of Abbott's board of directors or senior management failed to manage Abbott in an acceptable manner, in breach of their fiduciary duties to Abbott, and whether Abbott and its shareholders suffered damages as a result.

INVESTORS OF ABBOTT STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR ABBOTT STOCK HOLDINGS.

On May 16, 2022, the U.S. filed a lawsuit and proposed consent decree against Abbott claiming that Abbott manufactured powdered infant formula under conditions and using practices that failed to comply with regulations designed to ensure the quality and safety of infant formula.

IF YOU ARE AN ABBOTT SHAREHOLDER, YOU MAY HAVE LEGAL CLAIMS AGAINST ABBOTT'S DIRECTORS AND OFFICERS. PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, MYARNOFF@KEHOELAWFIRM.COM, INFO@KEHOELAWFIRM.COM, TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff-side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm, P.C. have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/136972